Adverse events related to bystander naloxone administration in cases of suspected opioid overdose in British Columbia: An observational study

<h4>Introduction</h4> Take-Home Naloxone programs have been introduced across North America in response to rising opioid overdose deaths. There is currently limited real-world data on bystander naloxone administration, overdose outcomes, and evidence related to adverse events following b...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Amina Moustaqim-Barrette, Kristi Papamihali, Sierra Williams, Max Ferguson, Jessica Moe, Roy Purssell, Jane A. Buxton
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/d7d12ac945ea4f28926692d2261ac3d2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d7d12ac945ea4f28926692d2261ac3d2
record_format dspace
spelling oai:doaj.org-article:d7d12ac945ea4f28926692d2261ac3d22021-11-04T07:42:09ZAdverse events related to bystander naloxone administration in cases of suspected opioid overdose in British Columbia: An observational study1932-6203https://doaj.org/article/d7d12ac945ea4f28926692d2261ac3d22021-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555799/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Introduction</h4> Take-Home Naloxone programs have been introduced across North America in response to rising opioid overdose deaths. There is currently limited real-world data on bystander naloxone administration, overdose outcomes, and evidence related to adverse events following bystander naloxone administration. <h4>Methods</h4> The research team used descriptive statistics from Take-Home Naloxone administration forms. We explored reported demographic variables and adverse events among people who received by-stander administered naloxone in a suspected opioid overdose event between August 31, 2012 and December 31, 2018 in British Columbia. We examined and contextualized differences across years given policy, program and drug toxicity changes. We used multivariate logistic regression to examine whether an association exists between number of ampoules of naloxone administered and the odds that the recipient will experience withdrawal symptoms. <h4>Results</h4> A large majority (98.1%) of individuals who were administered naloxone survived their overdose and 69.2% had no or only mild withdrawal symptoms. Receiving three (Adjusted Odds Ratio (AOR) 1.64 (95% Confidence Interval (CI): 1.08–2.48)) or four or more (AOR 2.19 (95% CI: 1.32–3.62)) ampoules of naloxone was significantly associated with odds of moderate or severe withdrawal compared to receiving one ampoule of naloxone. <h4>Conclusions</h4> This study provides evidence from thousands of bystander reversed opioid overdoses using Take-Home Naloxone kits in British Columbia, and suggests bystander-administered naloxone is safe and effective for opioid overdose reversal. Data suggests an emphasis on titration during bystander naloxone training in situations where the person experiencing overdose can be adequately ventilated may help avoid severe withdrawal symptoms. We identified a decreasing trend in the likelihood of moderate or severe withdrawal over the study period.Amina Moustaqim-BarretteKristi PapamihaliSierra WilliamsMax FergusonJessica MoeRoy PurssellJane A. BuxtonPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Amina Moustaqim-Barrette
Kristi Papamihali
Sierra Williams
Max Ferguson
Jessica Moe
Roy Purssell
Jane A. Buxton
Adverse events related to bystander naloxone administration in cases of suspected opioid overdose in British Columbia: An observational study
description <h4>Introduction</h4> Take-Home Naloxone programs have been introduced across North America in response to rising opioid overdose deaths. There is currently limited real-world data on bystander naloxone administration, overdose outcomes, and evidence related to adverse events following bystander naloxone administration. <h4>Methods</h4> The research team used descriptive statistics from Take-Home Naloxone administration forms. We explored reported demographic variables and adverse events among people who received by-stander administered naloxone in a suspected opioid overdose event between August 31, 2012 and December 31, 2018 in British Columbia. We examined and contextualized differences across years given policy, program and drug toxicity changes. We used multivariate logistic regression to examine whether an association exists between number of ampoules of naloxone administered and the odds that the recipient will experience withdrawal symptoms. <h4>Results</h4> A large majority (98.1%) of individuals who were administered naloxone survived their overdose and 69.2% had no or only mild withdrawal symptoms. Receiving three (Adjusted Odds Ratio (AOR) 1.64 (95% Confidence Interval (CI): 1.08–2.48)) or four or more (AOR 2.19 (95% CI: 1.32–3.62)) ampoules of naloxone was significantly associated with odds of moderate or severe withdrawal compared to receiving one ampoule of naloxone. <h4>Conclusions</h4> This study provides evidence from thousands of bystander reversed opioid overdoses using Take-Home Naloxone kits in British Columbia, and suggests bystander-administered naloxone is safe and effective for opioid overdose reversal. Data suggests an emphasis on titration during bystander naloxone training in situations where the person experiencing overdose can be adequately ventilated may help avoid severe withdrawal symptoms. We identified a decreasing trend in the likelihood of moderate or severe withdrawal over the study period.
format article
author Amina Moustaqim-Barrette
Kristi Papamihali
Sierra Williams
Max Ferguson
Jessica Moe
Roy Purssell
Jane A. Buxton
author_facet Amina Moustaqim-Barrette
Kristi Papamihali
Sierra Williams
Max Ferguson
Jessica Moe
Roy Purssell
Jane A. Buxton
author_sort Amina Moustaqim-Barrette
title Adverse events related to bystander naloxone administration in cases of suspected opioid overdose in British Columbia: An observational study
title_short Adverse events related to bystander naloxone administration in cases of suspected opioid overdose in British Columbia: An observational study
title_full Adverse events related to bystander naloxone administration in cases of suspected opioid overdose in British Columbia: An observational study
title_fullStr Adverse events related to bystander naloxone administration in cases of suspected opioid overdose in British Columbia: An observational study
title_full_unstemmed Adverse events related to bystander naloxone administration in cases of suspected opioid overdose in British Columbia: An observational study
title_sort adverse events related to bystander naloxone administration in cases of suspected opioid overdose in british columbia: an observational study
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/d7d12ac945ea4f28926692d2261ac3d2
work_keys_str_mv AT aminamoustaqimbarrette adverseeventsrelatedtobystandernaloxoneadministrationincasesofsuspectedopioidoverdoseinbritishcolumbiaanobservationalstudy
AT kristipapamihali adverseeventsrelatedtobystandernaloxoneadministrationincasesofsuspectedopioidoverdoseinbritishcolumbiaanobservationalstudy
AT sierrawilliams adverseeventsrelatedtobystandernaloxoneadministrationincasesofsuspectedopioidoverdoseinbritishcolumbiaanobservationalstudy
AT maxferguson adverseeventsrelatedtobystandernaloxoneadministrationincasesofsuspectedopioidoverdoseinbritishcolumbiaanobservationalstudy
AT jessicamoe adverseeventsrelatedtobystandernaloxoneadministrationincasesofsuspectedopioidoverdoseinbritishcolumbiaanobservationalstudy
AT roypurssell adverseeventsrelatedtobystandernaloxoneadministrationincasesofsuspectedopioidoverdoseinbritishcolumbiaanobservationalstudy
AT janeabuxton adverseeventsrelatedtobystandernaloxoneadministrationincasesofsuspectedopioidoverdoseinbritishcolumbiaanobservationalstudy
_version_ 1718445051904786432